Coverage
-
February 06, 2020
Two trade groups and a public interest law firm on Thursday urged the Ninth Circuit to block a California state law prohibiting pay-for-delay deals between branded and generic-drug makers, saying the law could lead to never-ending litigation.
4 other articles on this case.
View all »